Van Moorsel CJ - Search Results

1

Effects of gemcitabine on cis-platinum-DNA adduct formation and repair in a panel of gemcitabine and cisplatin-sensitive or -resistant human ovarian cancer cell lines.

Peters GJ, Van Moorsel CJ, Lakerveld B, Smid K, Noordhuis P, Comijn EC, Weaver D, Willey JC, Voorn D, Van der Vijgh WJ, Pinedo HM. Peters GJ, et al. Among authors: van moorsel cj. Int J Oncol. 2006 Jan;28(1):237-44. Int J Oncol. 2006. PMID: 16328001

2

Effect of gemcitabine and cis-platinum combinations on ribonucleotide and deoxyribonucleotide pools in ovarian cancer cell lines.

Van Moorsel CJ, Smid K, Voorn DA, Bergman AM, Pinedo HM, Peters GJ. Van Moorsel CJ, et al. Int J Oncol. 2003 Jan;22(1):201-7. doi: 10.3892/ijo.22.1.201. Int J Oncol. 2003. PMID: 12469205

3

Mechanisms of synergism between gemcitabine and cisplatin.

van Moorsel CJ, Veerman G, Vermorken JB, Voorn DA, Kroep JR, Bergman AM, Pinedo HM, Peters GJ. van Moorsel CJ, et al. Adv Exp Med Biol. 1998;431:581-5. doi: 10.1007/978-1-4615-5381-6_112. Adv Exp Med Biol. 1998. PMID: 9598132 Clinical Trial. No abstract available.

4

Combination chemotherapy studies with gemcitabine and etoposide in non-small cell lung and ovarian cancer cell lines.

van Moorsel CJ, Pinedo HM, Veerman G, Guechev A, Smid K, Loves WJ, Vermorken JB, Postmus PE, Peters GJ. van Moorsel CJ, et al. Biochem Pharmacol. 1999 Feb 15;57(4):407-15. doi: 10.1016/s0006-2952(98)00316-5. Biochem Pharmacol. 1999. PMID: 9933029

5

Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines.

van Moorsel CJ, Pinedo HM, Veerman G, Bergman AM, Kuiper CM, Vermorken JB, van der Vijgh WJ, Peters GJ. van Moorsel CJ, et al. Among authors: van der vijgh wj. Br J Cancer. 1999 Jun;80(7):981-90. doi: 10.1038/sj.bjc.6690452. Br J Cancer. 1999. PMID: 10362105 Free PMC article.

6

Pharmacokinetic schedule finding study of the combination of gemcitabine and cisplatin in patients with solid tumors.

van Moorsel CJ, Kroep JR, Pinedo HM, Veerman G, Voorn DA, Postmus PE, Vermorken JB, van Groeningen CJ, van der Vijgh WJ, Peters GJ. van Moorsel CJ, et al. Among authors: van groeningen cj, van der vijgh wj. Ann Oncol. 1999 Apr;10(4):441-8. doi: 10.1023/a:1008301522349. Ann Oncol. 1999. PMID: 10370787 Free article. Clinical Trial.

7

Scheduling of gemcitabine and cisplatin in Lewis lung tumour bearing mice.

van Moorsel CJ, Pinedo HM, Veerman G, Vermorken JB, Postmus PE, Peters GJ. van Moorsel CJ, et al. Eur J Cancer. 1999 May;35(5):808-14. doi: 10.1016/s0959-8049(99)00004-0. Eur J Cancer. 1999. PMID: 10505043

8

Gemcitabine and paclitaxel: pharmacokinetic and pharmacodynamic interactions in patients with non-small-cell lung cancer.

Kroep JR, Giaccone G, Voorn DA, Smit EF, Beijnen JH, Rosing H, van Moorsel CJ, van Groeningen CJ, Postmus PE, Pinedo HM, Peters GJ. Kroep JR, et al. Among authors: van moorsel cj. J Clin Oncol. 1999 Jul;17(7):2190-7. doi: 10.1200/JCO.1999.17.7.2190. J Clin Oncol. 1999. PMID: 10561275 Clinical Trial.

9

Gemcitabine-cisplatin: a schedule finding study.

Kroep JR, Peters GJ, van Moorsel CJ, Catik A, Vermorken JB, Pinedo HM, van Groeningen CJ. Kroep JR, et al. Among authors: van moorsel cj. Ann Oncol. 1999 Dec;10(12):1503-10. doi: 10.1023/a:1008339425708. Ann Oncol. 1999. PMID: 10643544 Free article. Clinical Trial.

10

Differential effects of gemcitabine on ribonucleotide pools of twenty-one solid tumour and leukaemia cell lines.

van Moorsel CJ, Bergman AM, Veerman G, Voorn DA, Ruiz van Haperen VW, Kroep JR, Pinedo HM, Peters GJ. van Moorsel CJ, et al. Biochim Biophys Acta. 2000 Mar 6;1474(1):5-12. doi: 10.1016/s0304-4165(99)00209-3. Biochim Biophys Acta. 2000. PMID: 10699484

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters